Retinal Microcirculation Changes in Crohn's Disease Patients under Biologics, a Potential Biomarker of Severity: A

Eloi Debourdeau1,2, Chloé Charmard1,2, Isabelle Carriere2

  • 1Department of Ophthalmology, Gui de Chauliac Hospital, F-34000 Montpellier, France.

Insights

Severe Crohn's disease (CD) alters retinal microcirculation, indicated by reduced vessel density and foveal avascular zone size. Optical Coherence Tomography Angiography (OCT-A) can detect these changes, reflecting systemic microvascular health in CD patients.

Area of Science:

  • Ophthalmology
  • Gastroenterology
  • Cardiovascular Research

Background:

  • Crohn's disease (CD) is linked to heightened cardiovascular risk.
  • Retinal microcirculation serves as a window into systemic microvascular health.
  • Investigating retinal changes may reveal disease severity indicators in CD.

Purpose of the Study:

  • To determine if retinal microcirculation is altered in relation to Crohn's disease severity.
  • To compare retinal microvascular parameters between moderate CD, severe CD, and healthy controls.

Main Methods:

  • A cross-sectional case-controlled study involving 74 CD patients and 74 controls.
  • Exclusion criteria included diabetes, renal disease, cardiovascular disease, and ophthalmological history.
  • Optical Coherence Tomography Angiography (OCT-A) was used to analyze retinal microcirculation.

Main Results:

  • Severe CD patients exhibited a significantly smaller foveal avascular zone (p=0.001) and reduced superficial macular capillary plexus vessel density (p=0.009) compared to controls.
  • Severe CD patients also showed reduced parafoveal thickness (p<0.001).
  • The foveal avascular zone was significantly smaller in severe CD patients than in moderate CD patients (p=0.010).

Conclusions:

  • Optical Coherence Tomography Angiography (OCT-A) can detect microcirculatory alterations in the retina of severe Crohn's disease patients.
  • These findings suggest retinal microvascular changes correlate with Crohn's disease severity.
  • OCT-A may serve as a non-invasive tool to assess systemic microvascular involvement in CD.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
249
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
282
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
231
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
435
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
443